Cargando…

Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study

OBJECTIVES: A correlation between hyperhomocysteinemia, and depression has been reported. Saffron (Crocus sativus) is recommended for treatment of depression; hence, in this study the effect of co-administration of saffron and fluoxetine on plasma homocysteine and depression was evaluated. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Jelodar, Gholamali, Javid, Zahra, Sahraian, Ali, Jelodar, Sina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787996/
https://www.ncbi.nlm.nih.gov/pubmed/29387573
_version_ 1783296038623248384
author Jelodar, Gholamali
Javid, Zahra
Sahraian, Ali
Jelodar, Sina
author_facet Jelodar, Gholamali
Javid, Zahra
Sahraian, Ali
Jelodar, Sina
author_sort Jelodar, Gholamali
collection PubMed
description OBJECTIVES: A correlation between hyperhomocysteinemia, and depression has been reported. Saffron (Crocus sativus) is recommended for treatment of depression; hence, in this study the effect of co-administration of saffron and fluoxetine on plasma homocysteine and depression was evaluated. MATERIAL AND METHODS: This was a 4-week randomized and double-blind clinical trial which was conducted from March 2013 to February 2014. In this trial, 40 male and females (20-55 years old) diagnosed with severe depression were selected and following filing the Beck form, were randomly divided into two groups. Experimental group was treated with fluoxetine 20 mg/day and saffron 30 mg /day and the control group received placebo and fluoxetine 20 mg/day for four weeks. Before treatment and at the end of the study, fasting blood samples were collected. For females, blood samples were collected on the third day of their menstrual cycle. RESULTS: A significant reduction of homocysteine levels was observed in both sex in the experimental group compared to before treatment (p<0.04), while no such significant change was observed in the control group. A Beck questionnaire value showed lower level in both groups on the last day of treatment as compared to before treatment. There was no significant difference between the two groups in Beck value neither before nor after treatment. CONCLUSION: Saffron has beneficial effects on depression and homocysteine level in patients with major depression.
format Online
Article
Text
id pubmed-5787996
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-57879962018-01-31 Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study Jelodar, Gholamali Javid, Zahra Sahraian, Ali Jelodar, Sina Avicenna J Phytomed Original Article OBJECTIVES: A correlation between hyperhomocysteinemia, and depression has been reported. Saffron (Crocus sativus) is recommended for treatment of depression; hence, in this study the effect of co-administration of saffron and fluoxetine on plasma homocysteine and depression was evaluated. MATERIAL AND METHODS: This was a 4-week randomized and double-blind clinical trial which was conducted from March 2013 to February 2014. In this trial, 40 male and females (20-55 years old) diagnosed with severe depression were selected and following filing the Beck form, were randomly divided into two groups. Experimental group was treated with fluoxetine 20 mg/day and saffron 30 mg /day and the control group received placebo and fluoxetine 20 mg/day for four weeks. Before treatment and at the end of the study, fasting blood samples were collected. For females, blood samples were collected on the third day of their menstrual cycle. RESULTS: A significant reduction of homocysteine levels was observed in both sex in the experimental group compared to before treatment (p<0.04), while no such significant change was observed in the control group. A Beck questionnaire value showed lower level in both groups on the last day of treatment as compared to before treatment. There was no significant difference between the two groups in Beck value neither before nor after treatment. CONCLUSION: Saffron has beneficial effects on depression and homocysteine level in patients with major depression. Mashhad University of Medical Sciences 2018 /pmc/articles/PMC5787996/ /pubmed/29387573 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jelodar, Gholamali
Javid, Zahra
Sahraian, Ali
Jelodar, Sina
Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study
title Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study
title_full Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study
title_fullStr Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study
title_full_unstemmed Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study
title_short Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study
title_sort saffron improved depression and reduced homocysteine level in patients with major depression: a randomized, double-blind study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787996/
https://www.ncbi.nlm.nih.gov/pubmed/29387573
work_keys_str_mv AT jelodargholamali saffronimproveddepressionandreducedhomocysteinelevelinpatientswithmajordepressionarandomizeddoubleblindstudy
AT javidzahra saffronimproveddepressionandreducedhomocysteinelevelinpatientswithmajordepressionarandomizeddoubleblindstudy
AT sahraianali saffronimproveddepressionandreducedhomocysteinelevelinpatientswithmajordepressionarandomizeddoubleblindstudy
AT jelodarsina saffronimproveddepressionandreducedhomocysteinelevelinpatientswithmajordepressionarandomizeddoubleblindstudy